Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kexin Meng
Observed names:
K. Meng,
Kalyan Meng
Institutions:
Calmette Hospital,
Shandong Provincial QianFoShan Hospital,
Shandong First Medical University,
Beijing InnoCare Pharma Tech Co., Ltd. (China)
Observed institutions:
Qingdao University,
Calmette Hospital,
Shandong Provincial QianFoShan Hospital,
Shandong First Medical University,
Beijing InnoCare Pharma Tech Co., Ltd. (China)
ORCID:
0009-0002-2645-2454
Observed ORCID:
0009-0002-2645-2454
OpenAlex ID:
A5030544105
Clinical application of high‐LET radiotherapy combined with immunotherapy in malignant tumors
2024
·
Kexin Meng
, Haijun Lu
·
Precision Radiation Oncology
·
31
PDF
The synergistic effects of anoikis-related genes and EMT-related genes in the prognostic prediction of Wilms tumor
2024
·
Kexin Meng
, Zerui Zhao
, et al.
·
Frontiers in Molecular Biosciences
·
4
Clinical Treatment Status of Papillary Thyroid Microcarcinoma
2025
·
Tong Liu
, Kexin Meng
, et al.
·
Advanced ultrasound in diagnosis and therapy
·
2
PDF
1456eP Gunagratinib, a highly selective irreversible FGFR inhibitor in patients with head and neck cancer harboring FGFR pathway alterations
2025
·
Y. Guo
, G. Zhu
, et al.
·
Annals of Oncology
PDF
Human papillomavirus infection among patients with cervical cancer in Cambodia
2025
·
Jacob E. Gardner
, Kyle Jung
, et al.
·
BMC Women s Health
PDF
Show more works
View as search
Works count:
5
Citation count:
37
H-index:
2
I10-index:
1
Year
Topic
Type
